Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
Growth Shares
5 explosive ASX growth shares to buy in FY 2020
Share Market News
It's not just broker upgrades sending the CSL share price higher
⏸️ ASX Shares
Where to invest $5,000 in ASX 200 shares in FY 2020
Share Market News
Leading brokers name 3 ASX shares to buy today
Share Market News
Can the Cochlear share price continue to beat the ASX 200?
Share Market News
Goldman Sachs tips CSL share price to climb to $223.00
Share Market News
This ASX growth share could be a winner for the absolute beginner investor
How to invest
How to become a millionaire by investing in ASX shares
Growth Shares
Where to invest $5,000 in ASX 200 shares this month
How to invest
How to turn $20,000 into $650,000 with ASX shares
⏸️ ASX Shares
3 ASX blue chip shares to buy in June
Share Market News
JP Morgan just SHOCKED the market with its RBA rate cut call
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
